In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington's disease subjects

By Faideau Mathilde   Kim Jinho   Cormier Kerry   Gilmore Richard   Welch Mackenzie   Auregan Gwennaelle   Dufour Noelle   Guillermier Martine   Brouillet Emmanuel   Hantraye Philippe   Dglon Nicole   Ferrante Robert J.   Bonvento Gilles  

Human Molecular Genetics, Vol. 19, Iss. 15, 2010-08 ,pp. : 3053-3067

Oxford University Press

Access to resources Recommend Favorite

Increased huntingtin protein length reduces the number of polyglutamine-induced gene expression changes in mouse models of Huntington's disease

By Chan Edmond Y.W.  

Human Molecular Genetics, Vol. 11, Iss. 17, 2002-06 ,pp. : 1939-1951

Oxford University Press

Access to resources Recommend Favorite

Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington's disease mouse models reveal context-independent effects

By Borchelt D.R.  

Human Molecular Genetics, Vol. 11, Iss. 17, 2002-06 ,pp. : 1927-1937

Oxford University Press

Access to resources Recommend Favorite

Rilmenidine attenuates toxicity of polyglutamine expansions in a mouse model of Huntington's disease

By Rose Claudia   Menzies Fiona M.   Renna Maurizio   Acevedo-Arozena Abraham   Corrochano Silvia   Sadiq Oana   Brown Steve D.   Rubinsztein David C.  

Human Molecular Genetics, Vol. 19, Iss. 11, 2010-06 ,pp. : 2144-2153

Oxford University Press

Access to resources Recommend Favorite

Cell cycle arrest enhances the in vitro cellular toxicity of the truncated Machado–Joseph disease gene product with an expanded polyglutamine stretch

By Yoshizawa Toshihiro   Yamagishi Yasuaki   Koseki Naoteru   Goto Jun  

Human Molecular Genetics, Vol. 9, Iss. 1, 2000-01 ,pp. : 69-78

Oxford University Press

Access to resources Recommend Favorite